M&A Deal Summary

Momenta Pharmaceuticals Acquires Parivid

On May 10, 2007, Momenta Pharmaceuticals acquired information services company Parivid

Acquisition Highlights
  • This is Momenta Pharmaceuticals’ 1st transaction in the Information Services sector.
  • This is Momenta Pharmaceuticals’ 1st transaction in the United States.
  • This is Momenta Pharmaceuticals’ 1st transaction in Massachusetts.

M&A Deal Summary

Date 2007-05-10
Target Parivid
Sector Information Services
Buyer(s) Momenta Pharmaceuticals
Deal Type Add-on Acquisition

Target

Parivid

Cambridge, Massachusetts, United States
Parivid LLC is a data integration and analysis services provider.

Search 177,729 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Momenta Pharmaceuticals

Cambridge, Massachusetts, United States

website


Category Company
Founded 2001
Sector Life Science
Employees131
Revenue 24M USD (2019)
DESCRIPTION

Momenta Pharmaceuticals, Inc. is a biotechnology company specializing in the detailed structural analysis of complex drugs. Momenta is applying its technology to the development of generic versions of complex drugs, biosimilar and potentially interchangeable biologics, and to the discovery and development of novel therapeutics for oncology and autoimmune indications. Momenta Pharmaceuticals was founded in 2001 and is based in Cambridge, Massachusetts.


DEAL STATS #
Overall 1 of 2
Sector (Information Services) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Massachusetts) 1 of 1
Country (United States) 1 of 2
Year (2007) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-12-05 Virdante Pharmaceuticals - Sialic Switch Assets

United States

Virdante Pharmaceuticals - Sialic Switch assets is a provider of novel therapeutic treatments for autoimmune and inflammatory disorders.

Buy $5M